Reported Earnings • Mar 17
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: ₩4,843 loss per share (down from ₩11,154 profit in FY 2024). Revenue: ₩3.28t (flat on FY 2024). Net loss: ₩21.6b (down 143% from profit in FY 2024). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 3.7% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. Annonce • Mar 07
HS Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 20, 2026 HS Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 20, 2026, at 11:00 Tokyo Standard Time. Location: auditorium, 119, mapo-daero, mapo-gu, seoul South Korea Price Target Changed • Feb 03
Price target increased by 10% to ₩272,500 Up from ₩247,500, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩261,000. Stock is up 49% over the past year. The company is forecast to post earnings per share of ₩464 for next year compared to ₩11,154 last year. Upcoming Dividend • Dec 22
Upcoming dividend of ₩6,500 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 02 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.4%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%). Declared Dividend • Nov 08
Dividend of ₩6,500 announced Dividend of ₩6,500 is the same as last year. Ex-date: 29th December 2025 Payment date: 2nd April 2026 Dividend yield will be 3.4%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 12x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 1,267% to bring the payout ratio under control. EPS is expected to grow by 329% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Annonce • Nov 07
Hs Hyosung Advanced Materials announces Annual dividend, payable on April 02, 2026 Hs Hyosung Advanced Materials announced Annual dividend of KRW 6500.0000 per share payable on April 02, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Price Target Changed • Oct 17
Price target decreased by 18% to ₩260,000 Down from ₩316,000, the current price target is an average from 3 analysts. New target price is 41% above last closing price of ₩184,900. Stock is down 29% over the past year. The company is forecast to post earnings per share of ₩11,442 for next year compared to ₩11,154 last year. Major Estimate Revision • Apr 12
Consensus EPS estimates increase by 11% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩17,775 to ₩19,753. Revenue forecast steady at ₩3.42b. Net income forecast to grow 78% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩303,333. Share price was steady at ₩169,800 over the past week. Reported Earnings • Mar 14
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: ₩11,154 (up from ₩10,057 in FY 2023). Revenue: ₩3.31t (up 3.4% from FY 2023). Net income: ₩49.8b (up 11% from FY 2023). Profit margin: 1.5% (up from 1.4% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.6%. Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance. Price Target Changed • Mar 01
Price target decreased by 7.1% to ₩306,667 Down from ₩330,000, the current price target is an average from 6 analysts. New target price is 64% above last closing price of ₩187,100. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩11,821 for next year compared to ₩7,957 last year. Annonce • Feb 27
Hs Hyosung Advanced Materials, Annual General Meeting, Mar 20, 2025 Hs Hyosung Advanced Materials, Annual General Meeting, Mar 20, 2025, at 11:00 Tokyo Standard Time. Location: auditorium, 119, mapo-daero, mapo-gu, seoul South Korea Valuation Update With 7 Day Price Move • Feb 10
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩196,000, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩351,582 per share. Major Estimate Revision • Feb 08
Consensus EPS estimates fall by 18% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩3.49b to ₩3.35b. EPS estimate also fell from ₩21,233 per share to ₩17,402 per share. Net income forecast to grow 222% next year vs 55% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩325,714. Share price rose 12% to ₩197,600 over the past week. Price Target Changed • Jan 17
Price target decreased by 9.2% to ₩351,429 Down from ₩387,143, the current price target is an average from 7 analysts. New target price is 95% above last closing price of ₩180,400. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₩12,780 for next year compared to ₩7,957 last year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩6,500 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 02 April 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.4%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%). Price Target Changed • Nov 08
Price target decreased by 8.5% to ₩431,429 Down from ₩471,250, the current price target is an average from 7 analysts. New target price is 106% above last closing price of ₩209,000. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩12,816 for next year compared to ₩7,957 last year. Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩221,500, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total loss to shareholders of 61% over the past three years. Major Estimate Revision • Oct 21
Consensus EPS estimates fall by 10% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.38b to ₩3.35b. EPS estimate also fell from ₩23,006 per share to ₩20,646 per share. Net income forecast to grow 278% next year vs 56% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩497,500 to ₩471,250. Share price fell 4.8% to ₩260,000 over the past week. Reported Earnings • Aug 17
Second quarter 2024 earnings released: EPS: ₩4,364 (vs ₩2,700 in 2Q 2023) Second quarter 2024 results: EPS: ₩4,364 (up from ₩2,700 in 2Q 2023). Revenue: ₩840.5b (up 3.0% from 2Q 2023). Net income: ₩19.5b (up 62% from 2Q 2023). Profit margin: 2.3% (up from 1.5% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩273,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 49% over the past three years. Major Estimate Revision • Jul 30
Consensus EPS estimates fall by 16% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.49b to ₩3.38b. EPS estimate also fell from ₩27,573 per share to ₩23,226 per share. Net income forecast to grow 412% next year vs 45% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩505,000. Share price fell 5.9% to ₩312,500 over the past week. Reported Earnings • May 19
First quarter 2024 earnings released: EPS: ₩4,523 (vs ₩7,397 in 1Q 2023) First quarter 2024 results: EPS: ₩4,523 (down from ₩7,397 in 1Q 2023). Revenue: ₩836.8b (flat on 1Q 2023). Net income: ₩20.2b (down 39% from 1Q 2023). Profit margin: 2.4% (down from 4.0% in 1Q 2023). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Reported Earnings • Mar 09
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: ₩7,957 (down from ₩28,053 in FY 2022). Revenue: ₩3.20t (down 17% from FY 2022). Net income: ₩35.6b (down 72% from FY 2022). Profit margin: 1.1% (down from 3.3% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 7.3% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Major Estimate Revision • Jan 30
Consensus EPS estimates fall by 36% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.54b to ₩3.36b. EPS estimate also fell from ₩32,794 per share to ₩20,938 per share. Net income forecast to grow 75% next year vs 73% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩522,857. Share price was steady at ₩338,000 over the past week. Upcoming Dividend • Dec 20
Upcoming dividend of ₩15,000 per share at 3.9% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 04 April 2024. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.9%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). Buying Opportunity • Nov 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 8.8%. The fair value is estimated to be ₩494,021, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 13% in 2 years. Earnings is forecast to grow by 276% in the next 2 years. Price Target Changed • Nov 01
Price target decreased by 9.9% to ₩515,000 Down from ₩571,667, the current price target is an average from 6 analysts. New target price is 42% above last closing price of ₩361,500. Stock is up 12% over the past year. The company is forecast to post earnings per share of ₩14,438 for next year compared to ₩28,053 last year. Buying Opportunity • Oct 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 20%. The fair value is estimated to be ₩440,235, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 5.7% in 2 years. Earnings is forecast to grow by 142% in the next 2 years. Major Estimate Revision • Oct 25
Consensus EPS estimates fall by 15% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.30b to ₩3.26b. EPS estimate also fell from ₩23,959 per share to ₩20,376 per share. Net income forecast to grow 78% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩598,333 to ₩571,667. Share price was steady at ₩355,000 over the past week. Major Estimate Revision • Oct 23
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩25,211 to ₩22,413 per share. Revenue forecast steady at ₩3.29b. Net income forecast to grow 89% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩598,333 to ₩583,333. Share price fell 9.2% to ₩338,500 over the past week. Buying Opportunity • Sep 01
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 2.7%. The fair value is estimated to be ₩562,655, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 6.1% in 2 years. Earnings is forecast to grow by 168% in the next 2 years. New Risk • Aug 26
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 19% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 97% Cash payout ratio: 96% Minor Risk Profit margins are more than 30% lower than last year (2.0% net profit margin). Buying Opportunity • Aug 10
Now 20% undervalued Over the last 90 days, the stock is up 7.7%. The fair value is estimated to be ₩568,259, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 1.6% in 2 years. Earnings is forecast to grow by 73% in the next 2 years. Major Estimate Revision • Aug 02
Consensus EPS estimates fall by 18% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.36b to ₩3.30b. EPS estimate also fell from ₩33,311 per share to ₩27,227 per share. Net income forecast to grow 31% next year vs 32% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩598,000. Share price rose 5.4% to ₩475,500 over the past week. Major Estimate Revision • Jul 13
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.47b to ₩3.36b. EPS estimate also fell from ₩38,283 per share to ₩33,311 per share. Net income forecast to grow 57% next year vs 34% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩587,500. Share price rose 2.0% to ₩451,000 over the past week. Price Target Changed • May 18
Price target increased by 7.4% to ₩580,000 Up from ₩540,000, the current price target is an average from 4 analysts. New target price is 33% above last closing price of ₩436,500. Stock is down 4.3% over the past year. The company is forecast to post earnings per share of ₩38,283 for next year compared to ₩28,053 last year. Reported Earnings • Mar 10
Full year 2022 earnings released: EPS: ₩28,053 (vs ₩56,109 in FY 2021) Full year 2022 results: EPS: ₩28,053 (down from ₩56,109 in FY 2021). Revenue: ₩3.84t (up 6.8% from FY 2021). Net income: ₩125.3b (down 50% from FY 2021). Profit margin: 3.3% (down from 7.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.6% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 89% per year whereas the company’s share price has increased by 84% per year. Upcoming Dividend • Dec 21
Upcoming dividend of ₩10,000 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 04 April 2023. Payout ratio is a comfortable 25% and the cash payout ratio is 83%. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%). Price Target Changed • Nov 16
Price target decreased to ₩550,000 Down from ₩648,333, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₩396,000. Stock is down 39% over the past year. The company is forecast to post earnings per share of ₩40,964 for next year compared to ₩56,109 last year. Price Target Changed • Nov 03
Price target decreased to ₩587,500 Down from ₩648,333, the current price target is an average from 4 analysts. New target price is 82% above last closing price of ₩323,000. Stock is down 53% over the past year. The company is forecast to post earnings per share of ₩44,900 for next year compared to ₩56,109 last year. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩336,500, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 172% over the past three years. Price Target Changed • Sep 26
Price target decreased to ₩625,000 Down from ₩675,000, the current price target is an average from 6 analysts. New target price is 81% above last closing price of ₩344,500. Stock is down 57% over the past year. The company is forecast to post earnings per share of ₩44,900 for next year compared to ₩56,109 last year. Reported Earnings • Aug 15
Second quarter 2022 earnings released: EPS: ₩10,197 (vs ₩16,930 in 2Q 2021) Second quarter 2022 results: EPS: ₩10,197 (down from ₩16,930 in 2Q 2021). Revenue: ₩1.02t (up 18% from 2Q 2021). Net income: ₩45.6b (down 40% from 2Q 2021). Profit margin: 4.4% (down from 8.7% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 24% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jul 07
Price target decreased to ₩675,000 Down from ₩744,800, the current price target is an average from 6 analysts. New target price is 84% above last closing price of ₩367,500. Stock is down 28% over the past year. The company is forecast to post earnings per share of ₩52,362 for next year compared to ₩56,109 last year. Reported Earnings • Mar 12
Full year 2021 earnings: EPS misses analyst expectations Full year 2021 results: EPS: ₩56,109 (up from ₩18.00 in FY 2020). Revenue: ₩3.60t (up 50% from FY 2020). Net income: ₩250.7b (up ₩250.6b from FY 2020). Profit margin: 7.0% (up from 0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.1%. Over the next year, revenue is forecast to grow 1.7%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth. Annonce • Jan 30
Hyosung Advanced Materials Corporation to Report Q4, 2021 Results on Feb 07, 2022 Hyosung Advanced Materials Corporation announced that they will report Q4, 2021 results on Feb 07, 2022 Major Estimate Revision • Jan 30
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩57,267 to ₩41,940. Revenue forecast unchanged from ₩3.45b at last update. Net income forecast to shrink 2.8% next year vs 36% growth forecast for Chemicals industry in South Korea . Consensus price target of ₩822,000 unchanged from last update. Share price fell 13% to ₩423,000 over the past week. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩422,000, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 269% over the past three years. Price Target Changed • Dec 23
Price target increased to ₩822,000 Up from ₩744,800, the current price target is an average from 6 analysts. New target price is 29% above last closing price of ₩635,000. Stock is up 338% over the past year. The company is forecast to post earnings per share of ₩61,954 for next year compared to ₩17.60 last year. Valuation Update With 7 Day Price Move • Dec 07
Investor sentiment improved over the past week After last week's 15% share price gain to ₩716,000, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 534% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩437,449 per share. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩717,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 441% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩431,222 per share. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩717,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 441% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩431,222 per share. Valuation Update With 7 Day Price Move • Sep 14
Investor sentiment improved over the past week After last week's 22% share price gain to ₩741,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩402,937 per share. Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 18% share price gain to ₩625,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 303% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩392,425 per share. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment improved over the past week After last week's 16% share price gain to ₩568,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 235% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩248,498 per share. Price Target Changed • May 08
Price target increased to ₩508,750 Up from ₩448,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩393,000. Stock is up 353% over the past year. Price Target Changed • Mar 25
Price target increased to ₩386,250 Up from ₩331,250, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩381,000. Stock is up 550% over the past year. Annonce • Feb 27
Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 18, 2021 Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 18, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Feb 17
New 90-day high: ₩316,000 The company is up 117% from its price of ₩145,500 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩348,944 per share. Price Target Changed • Jan 30
Price target raised to ₩201,750 Up from ₩176,750, the current price target is an average from 4 analysts. The new target price is 11% below the current share price of ₩226,500. As of last close, the stock is up 127% over the past year. Annonce • Jan 28
Hyosung Advanced Materials Corporation(KOSE:A298050) dropped from FTSE All-World Index (USD) Hyosung Advanced Materials Corporation(KOSE:A298050) dropped from FTSE All-World Index (USD) Is New 90 Day High Low • Jan 28
New 90-day high: ₩233,500 The company is up 75% from its price of ₩133,500 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 34% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩178,114 per share. Is New 90 Day High Low • Jan 07
New 90-day high: ₩160,000 The company is up 10.0% from its price of ₩145,500 on 08 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩191,507 per share. Is New 90 Day High Low • Oct 26
New 90-day low: ₩122,500 The company is down 4.0% from its price of ₩128,000 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩206,785 per share.